Change and Recovery of Choroid Thickness after Short-term Application of 1% Atropine Gel and Its Influencing Factors in 6-7-year-old Children.


Journal

Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 5 1 2021
medline: 22 1 2022
entrez: 4 1 2021
Statut: ppublish

Résumé

To investigate the change and recovery of choroid thickness after short-term application of 1% atropine gel and its influencing factors in 6-7-year-old children. 71 right eyes of 71 children were enrolled and divided into myopia and control group. 1% atropine gel was administered twice a day for one week and then stopped. Spherical equivalent (SE), accommodative amplitude (AA), keratometry (K), axial length (AL), and choroidal thickness (CT) were obtained at baseline and 1 In both groups, all CTs increased following the change in SE, AA, and AL after administration of 1% atropine for one week. They gradually recovered to baseline levels seven weeks after withdrawal. The change (Δ) in CT at 3 mm superior from the fovea was significantly higher in the myopia group than in the control group. In both groups, ΔCT at subfovea had no significant correlation with SE, AA, and AL, both at baseline and one week. However, ΔCT at subfovea was negatively correlated with ΔAL in the control group. One-week application of 1% atropine gel may increase CT in 6-7-year-old Chinese children. Meanwhile, the recovery process after withdrawal lasts seven weeks. During the recovery process, the changes in structural parameters (AL, CT) and functional parameters (AA, SE) in both groups occurred synchronously. The SE, AA, and AL at baseline may not predict the extent of atropine's effect on CT.

Identifiants

pubmed: 33390025
doi: 10.1080/02713683.2020.1863431
doi:

Substances chimiques

Gels 0
Muscarinic Antagonists 0
Atropine 7C0697DR9I

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1171-1177

Auteurs

Yunjia Jiang (Y)

Department of Ophthalmology, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
Department of Ophthalmology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Department of Ophthalmology, The Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu Province, China.

Zhengwei Zhang (Z)

Department of Ophthalmology, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
Department of Ophthalmology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Department of Ophthalmology, The Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu Province, China.

Zhifeng Wu (Z)

Department of Ophthalmology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Department of Ophthalmology, The Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu Province, China.

Song Sun (S)

Department of Ophthalmology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Department of Ophthalmology, The Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu Province, China.

Yuting Fu (Y)

Department of Ophthalmology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, China.
Department of Ophthalmology, The Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu Province, China.

Bilian Ke (B)

Department of Ophthalmology, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
Department of Ophthalmology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
National Clinical Research Center for Eye Diseases, Shanghai, China.
Shanghai Key Laboratory of Fundus Disease, Shanghai, China.
Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.
Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH